пятница, 25 ноября 2016 г.

J&J Said to Make Takeover Approach for Swiss Drugmaker Actelion 31 minutes ago

J&J Said to Make Takeover Approach for Swiss Drugmaker Actelion 31 minutes ago


Johnson & Johnson has approached Actelion Ltd. about a potential takeover of the $17 billion Swiss drugmaker as the U.S. health-care giant works to expand its pharmaceutical lineup, people familiar with the matter said. Deliberations are still at an early stage following J&J's initial offer, the people said, asking not to be identified because the talks are private.



from Biotech News